DSM-V research agenda: Substance abuse/psychosis comorbidity

Schizophrenia Bulletin

Volumn 33, Issue 4, 2007, Pages 947-952

  Rounsaville, Bruce J ^a  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Alcohol; DSM V; Psychiatric diagnosis; Psychiatric epidemiology; Psychosis; Substance use disorders

Indexed keywords

CANNABIS;

BIPOLAR DISORDER; CANNABIS ADDICTION; COMORBIDITY; CONFERENCE PAPER; DELIRIUM; DEMENTIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE DURATION; HUMAN; INTOXICATION; NEUROBIOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SUBSTANCE ABUSE; SYMPTOMATOLOGY; SYSTEMATIC REVIEW;

COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; PRACTICE GUIDELINES; PSYCHOTIC DISORDERS; SUBSTANCE-RELATED DISORDERS;

EID: 34547674619     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbm054     Document Type: Conference Paper

References (29)

1. Rosenthal RN, Miner CR. Differential diagnosis of substanceinduced psychosis and schizophrenia in patients with substance use disorders. Schizophr Bull. 1997;23:187-193.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
3. Fennig S, Bromet EJ, Craig T, Jandorf L, Schwartz JE. Psychotic patients with unclear diagnoses: a descriptive analysis. J Nerv Ment Dis. 1995;183:207-213.
4. Shaner A, Roberts LJ, Racenstein JM, Eckman TA, Tsuang JW, Tucker DE. Sources of diagnostic uncertainty among chronically psychotic cocaine abusers. 149th Annual Meeting of the American Psychiatric Association; May 4-9, 1996; New York, NY.
5. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry. 1970;126:983-987.
6. Kendler KS. Toward a scientific psychiatric nosology: strengths and limitations. Arch Gen Psychiatry. 1990;47:969-973.
7. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry. 1997;54:313-321.
8. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiological Catchment Area (ECA) Study. JAMA. 1990;264:2511-2518.
9. Ziedonis D, Steinberg ML, D'Avanzo K, Smelson D. Cooccuring schizophrenia and addiction. In: Kranzler HR, Tinsley JA, eds. Dual Diagnosis and Psychiatric Treatment: Substance Abuse and Comorbid Disorders. 2nd ed. New York, NY: Marcel Dekker, Inc. 1998:427-466.
10. Mueser KT, Bellack AS, Blanchard JJ. Comorbidity of schizophrenia and substance abuse: implications for treatment. J Consult Clin Psychol. 1992;47:1102-1114.
11. Lehman AF, Myers CP, Corty E, Thompson JW. Prevalence and patterns of "dual diagnosis" among psychiatric inpatients. Compr Psychiatry. 1994;35:106-112.
12. Schneier FR, Siris SG. A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice. J Nerv Ment Dis. 1987;175:641-652.
13. Schuckit MA. Comorbidity between substance use disorders and psychiatry conditions. Addiction. 2006;101:(suppl 1) 76-88.
14. Henquet C, Murray R, Linszen D, van Os J. The environment and schizophrenia: the role of cannabis use. Schizophr Bull. 2005;31:608-612.
15. Caspi A, Moffitt TE, Cannon M, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene x environment interaction. Biol Psychiatry. 2005;57:1117-1127.
16. Kendall RE. The distinction between mental and physical illness. Br J Psychiatry. 2001;178:490-493.
17. Caton CLM, Drake RE, Hasin DS, et al. Differences between early phase primary psychotic disorders with concurrent substance use and substance-induced psychosis. Arch Gen Psychiatry. 2005;62:137-145.
18. Chen C-K, Lin S-K, Sham PC, et al. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol Med. 2003;33:1407-1414.
19. Griffith JD. Experimental psychosis induced by the administration of d-amphetamine. In: Costa E, Garattini S, eds. Amphetamine and Related Compounds. New York, NY: Raven Press; 1970:876-904.
20. Janowsky DS, Risch C. Amphetamine psychosis and psychotic symptoms. Psychopharmacology. 1979;65:73-77.
21. Boutros N, Bowers M. Chronic substance-induced psychotic disorders: state of the literature. J Neuropsychiatry Clin Neurosci. 1996;8:470-484.
22. Lee C, McGlashan TH, Wood SW. Prevention of schizophrenia: can it be achieved? CNS Drugs. 2005;19:193-206.
23. Taminga C, Van Os J. Deconstructing psychosis: introduction and overview of special issue. Schizophr Bull. In press.
24. Robins LN. Using survey results to improve the validity of the standard psychiatric nomenclature. Arch Gen Psychiatry. 2004;61:1188-1194.
25. Swart K, Pratt LA, Armenian HK, Lee LC, Eaton WW. Mental disorders and the incidence of migraine headaches in a community sample: results from the Baltimore Epidemiologic Catchment Area follow-up study. Arch Gen Psychiatry. 2000;57:945-950.
26. Kessler RC, Berglund P, Demier O, et al. The epidemiology of major depressive disorder, results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095-3105.
27. Breslau N, Peterson ES, Schultz LR, Chilcoat HD, Andreski P. Major depression and stages of smoking: a longitudinal investigation. Arch Gen Psychiatry. 1998;55:161-166.
28. Cottler LB, Grant BF. Characteristics of nosologically informative data sets that address key diagnostic issues facing the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V) and the International Classification of Diseases, eleventh edition (ICD-11) substance use disorders workgroups. Addiction. 2006;101:(suppl 1)161-169.
29. Rounsaville BJ, Alarcon RD, Andrews G, Jackson JS, Kendall RE, Kendler K. Basic nomenclature issues. In: Kupfer D, First M, Regier D, eds. APA Research Agenda for DSM-V. Washington, DC: American Psychiatric Association Press; 2002:pp. 1-30.